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Infections occurring in the lower female genital tract rep-
resent a complex topic from several diﬀerent viewpoints.
First, there is a body of scientific knowledge and clinical
consequences associated with these infections. Second, the
complexity is increased by the biological diversity of infec-
tious organisms involved including bacteria, fungi, virus,
and protozoan life forms. A third layer of complexity
exists in the interaction between the host and infectious
organisms through the inflammatory responses to infections
and through the elaboration of host factors such as secreted
antibodies and defensin molecules inhibitory to intravaginal
microorganisms. Finally, the vagina is host to an indigenous
microbiota which is credited with contributing to vaginal
health, but also the flora interacts with exogenous microor-
ganisms involved in pathogenesis of vaginal infections.
It is striking that despite the fact that the vaginal flora
has been a topic of interest to physicians and scientists since
the last decade of the 19th century, there is still much to
be learned and newer research techniques are continuing to
elucidate our understanding of the vaginal flora, infectious
agents involved in pathogenic interactions with the host, and
the eﬀects of indigenous and exogenous organisms on the
physiology of the vagina. Because of continuing discoveries,
the oﬀering of the present special issue is an appropriate
venue for presentation of current thinking about vaginal
infections. The editors are pleased to present the articles
published in this issue.
As mentioned above, the vaginal infections derive from
a biologically diverse collection of microbes. Thus, the
reader will find that this organisms represented in this issue
include bacteria (Group B Streptococcus in the A. Lambiase
et al. article, Treponema pallidum in the M. de Santis et
al. contribution, and Lactobacilli and bacterial vaginosis
associated bacteria in the works of J. M. Bohbot and J. M.
Cardot, C. Mitchell et al.). Viral pathogens are represented by
Herpes Simplex in the G. Straface et al. article, HIV in the C.
Vallone et al. contribution, and HPV in the M. Guadalupe et
al. paper. Candida species are addressed by A. Palmeira-de-
Oliviera and coworkers, while the continuum of biological
forms is rounded out by the R. Sehgal et al. paper which
focuses on Trichomonas.
Another aspect of vaginal infections is the diversity
and disparity of epidemiologic details depending on both
geography and ethnicity of the populations studied. Several
articles in this issue provide information about populations
derived from various locations across the globe. It is always
useful to become informed about common issues along with
diﬀerences in prevalence and manifestations at locations
other than one’s own practice site.
In addition to eﬀorts of physicians and scientists to define
and characterize vaginal infections in terms of microbiology
and pathophysiology, there is always the overarching ques-
tion of how we can best deal with these clinical conditions
through available or new therapies. The prevailing logic
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of using antibiotics to deal with these issues has been
both logically and widely applied since the discovery of
penicillin in the middle of the last century. But as indicated
by M. de Santis et al. review that despite highly eﬀective
penicillin applied to treating syphilis, the disease has not
been eradicated and congenital syphilis in particular remains
a continuing problem. Certainly history has reminded us
that the ability of microorganisms to develop resistance to
antimicrobial drugs has altered are ability to treat some
infections. A. Lambiase and coworkers have explored the
occurrence of resistance to macrolides and clindamycin
among GBS isolates in Italy. Likewise antiviral drugs may
interfere with neonatal infection with Herpes Simplex during
pregnancy (G. Straface et al.). In addition to traditional
antibiotics, investigators are continuing to discover unan-
ticipated antimicrobial attributes of drugs as illustrated by
the work of A. Palmeria-de-Oliviera et al. who studied the
anti-Candida activity of nitroglycerine and lidocaine. As
with any compound with antimicrobial activity in vitro, the
translation of the initial findings to clinical use will be a
continuing challenge.
Knowing that antibiotics, despite phenomenal historical
successes, have not been able to provide a full and final
answer to vaginal infections, investigators have turned their
attention to exploiting host defense mechanisms in a variety
of ways and employing various mechanisms of action. For
example, based on the concept that normal flora organisms
promote vaginal health, the use of probiotic organisms
continues to be studied in relation to bacterial vaginosis
(see J. M. Bohbot and J. M. Cardot). In addition to
probiotics, known host defense factors have been studied as
potential therapeutic drugs. A review of the possible value of
lactoferrin as a therapy for the very prevalent Trichomonas
vaginalis was examined by R. Sehgal and coworkers.
This issue should serve as a reminder thatmany questions
remain about the content of the healthy vagina and the
specific organisms capable of producing symptomatic infec-
tion. The challenge for the future is to continue to examine
both the science behind vulvovagianl infectious pathology
and to devise clinically relevant therapeutic approaches to
the problems that continue to make women uncomfortable,
undermine the quality of life, and in some cases threaten
their overall health and the health of their fetuses and infants.
We owe it to our wives, mothers, and daughters to continue
to bring our intellectual eﬀorts to bear on developing
creative approaches to understanding and addressing vaginal
infections of all types and in all populations no matter where
they are in the world.
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